Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance.

CONCLUSION: These findings highlighted the clinical utility of serial tumour markers measurements and its velocity in breast cancer surveillance.
PMID: 32485607 [PubMed - as supplied by publisher]

Source: Breast - May 19, 2020 Category: Cancer & Oncology Authors: Hing JX, Mok CW, Tan PT, Sudhakar SS, Seah CM, Lee WP, Tan SM Tags: Breast Source Type: research